APA (7th ed.) Citation

R, D., T, L., V, A., H, E., H, L. B., G, C., . . . M, G. (2021). TAVR Patients Requiring Anticoagulation: Direct Oral Anticoagulant or Vitamin K Antagonist? JACC. Cardiovascular interventions, 14(15), 1704. https://doi.org/10.1016/j.jcin.2021.05.025

Chicago Style (17th ed.) Citation

R, Didier, et al. "TAVR Patients Requiring Anticoagulation: Direct Oral Anticoagulant or Vitamin K Antagonist?" JACC. Cardiovascular Interventions 14, no. 15 (2021): 1704. https://doi.org/10.1016/j.jcin.2021.05.025.

MLA (9th ed.) Citation

R, Didier, et al. "TAVR Patients Requiring Anticoagulation: Direct Oral Anticoagulant or Vitamin K Antagonist?" JACC. Cardiovascular Interventions, vol. 14, no. 15, 2021, p. 1704, https://doi.org/10.1016/j.jcin.2021.05.025.